HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LB42708

farnesyltransferase inhibitor; structure in first source
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kim, Young-Myeong: 2 articles (07/2010 - 07/2004)
2. Lee, Hansoo: 2 articles (07/2010 - 07/2004)
3. Kwon, Young-Guen: 2 articles (07/2010 - 07/2004)
4. Ha, Kwon-Soo: 2 articles (07/2010 - 07/2004)
5. Kim, Dong Eun: 1 article (10/2014)
6. Kim, Ki Ho: 1 article (10/2014)
7. Jang, Ji Hoon: 1 article (10/2014)
8. Park, Jun-Soo: 1 article (10/2014)
9. Jang, Byeong-Churl: 1 article (10/2014)
10. Lee, Kyung Seop: 1 article (10/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Inflammation
3. Carcinoma (Carcinomatosis)
4. Arthritis (Polyarthritis)

Related Drugs and Biologics

1. LB42908
2. 7- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)
3. Cyclooxygenase 2 (Cyclooxygenase-2)
4. Farnesyltranstransferase (Farnesyltransferase)
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. Nitric Oxide Synthase (NO Synthase)
7. NF-kappa B (NF-kB)
8. Proto-Oncogene Proteins p21(ras)
9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)